FDA compliance, medical and affiliate disclosures for Vasoryn and this website.
These statements have not been evaluated by the U.S. Food & Drug Administration. Vasoryn is a dietary supplement, not a drug, and is not intended to diagnose, treat, cure or prevent any disease, including hypertension, heart disease or any other diagnosed cardiovascular condition. It is designed to support healthy blood pressure already within a normal range, circulation and heart wellness as part of a balanced diet and active lifestyle. Individual results vary. Vasoryn contains Hawthorn Berry, Garlic Extract and Beetroot Extract, which can affect blood pressure and circulation and may interact with blood pressure medication, blood thinners, or other prescription drugs, increasing the risk of low blood pressure or bleeding. This product is not intended for use by anyone under 18, or by pregnant or nursing individuals without medical guidance. Consult your doctor before use if you have a diagnosed cardiovascular condition or take prescription medication.
The content on VasorynOfficial.com, including blog articles, reviews and FAQs, is provided for general informational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional before starting Vasoryn or any new dietary supplement, particularly if you have a cardiovascular condition or take blood pressure medication.
Vasoryn contains Hawthorn Berry, Garlic Extract and Beetroot Extract, which can affect blood pressure and circulation and may interact with blood pressure medication or blood thinners, increasing the risk of low blood pressure or bleeding. Consult your doctor before use if this applies to you.
Testimonials and reviews on this site reflect individual experiences and are not guarantees of results. Factors such as diet, activity level, age and overall health can all affect outcomes.
This website may earn a commission on purchases made through links to the official Vasoryn store, at no additional cost to you. This does not influence our editorial assessments — see our editorial standards.